SE Asia Course II: Immunotherapy in Lung Cancer

Regional Course Series - SE Asia

Description

This exclusive course offers the latest updates on lung cancer treatment in Southeast Asia, with a special focus on immunotherapy. In Series II, renowned thoracic oncology experts from the region will delve into the role of immunotherapy in revolutionizing lung cancer care. Discussions will cover crucial topics such as the integration of biomarkers for immunotherapy, the best management strategies for advanced disease, and addressing challenges like pneumonitis. Join us to explore how immunotherapy is transforming the landscape of lung cancer treatment in Southeast Asia, bringing hope for improved patient outcomes.

 

Image
Regional Series - SE Asia 2

Learning Objectives

Discuss the role of immunotherapy across all stages of lung cancer.

Date and Time
Dec 16, 2024 4:00 am -
Location

Zoom

CME Accredited